2008
福岡県医学会, 平成２１年度 一般演題（ポスター）優秀賞
小型肺腺癌における予後因子としての微小乳頭状構造（micropapillary pattern)：臨床病理学的解析と浸潤形態, Japan society

Midline Glioma in Adults: Clinicopathological, Genetic, and Epigenetic Analysis.
Enomoto T; Aoki M; Hamasaki M; Abe H; Nonaka M; Inoue T; Nabeshima K
Neurol Med Chir, 15 Mar. 2020, 60(3):136 - 146, Refereed

CD73 complexes with emmprin to regulate MMP-2 production from co-cultured sarcoma cells and fibroblasts
AOKI Mikiko; KOGA Kaori
BMC Cancer, 23 Sep. 2019, Refereed

Adenoid cystic carcinoma with high-grade transformation forming spindle cell component of the submandibular gland
Miyazaki Masarua; Aoki Mikiko; Koga Kaori; Hamasaki Makoto; Sugiyama Yoshikazu; Midorikawa Kensuke; Hamatake Daisuke; Masaki Michio; Takamatsu Yasushi; Iwasaki Akinori; Sakata Toshifumi; Nagao Toshitaka; Nabeshima Kazuki
Auris Nasus Larynx, 16 Feb. 2019, 46(6):934 - 939, Refereed

Activated EphA2 Processing by MT1-MMP Is Involved in Malignant Transformation of Ovarian Tumours In Vivo.
Yoko Takahashi; Makoto Hamasaki; Mikiko Aoki; Kaori Koga; Naohiko Koshikawa; Shingo Miyamoto; Kazuki Nabeshima
Anticancer research, Jul. 2018, 38(7):4257 - 4266, Refereed

A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.
Kinoshita Y; Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Hiroshima K; Oda Y; Nabeshima K
Cancer, 31 Jan. 2018, 126(1):66 - 71, Refereed

肺癌を合併したpleuroparenchymal fibroelastosisの1例
木下義晃; 渡辺憲太朗; 石井寛; 吉村雅代; 濱崎慎; 鍋島一樹
診断病理, Jan. 2018, 35(1):66 - 71, Refereed

Intraoperative Squash and Touch Preparation Cytology of Brain Lesions Stained with H+E and Diff-Quik™: A 20-Year Retrospective Analysis and Comparative Literature Review.
Hamasaki M; Chang KHF; Nabeshima K; Tauchi-Nishi PS
Acta Cytol, 31 Dec. 2017, Refereed

Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry.
Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Iwasaki A; Okamoto T; Oda Y; Honda H; Nabeshima K
Lung Cancer, 01 Dec. 2017, 104:98 - 105, Refereed

Emmprin, released as a microvesicle in epithelioid sarcoma, interacts with fibroblasts.
Aoki M; Koga K; Hamasaki M; Egawa N; Nabeshima K
Int J Oncol, 01 Dec. 2017, 50(6):2229 - 2235, Refereed

Analysis of Evolving Clinicopathological Features of Metastatic Brain Tumors Over 30 Years of Surgical Management.
Kobayashi H; Hamasaki M; Morishita T; Inoue T; Nabeshima K
Anticancer Res, 01 Dec. 2017, 37(7):3969 - 3974, Refereed

Diagnostic application of BAP1 immunohistochemistry to differentiate pleural mesothelioma from metastatic pleural tumours
Masayo Yoshimura; Yoshiaki Kinoshita; Makoto Hamasaki; Shinji Matsumoto; Tomoyuki Hida; Yoshinao Oda; Kazuki Nabeshima
HISTOPATHOLOGY, Dec. 2017, 71(6):1011 - 1014, Refereed

Use of p16 FISH for differential diagnosis of mesothelioma in smear preparations.
Nabeshima K; Matsumoto S; Hamasaki M; Hida T; Kamei T; Hiroshima K; Tsujimura T; Kawahara K
Diagn Cytopathol, 01 Dec. 2016, 44(9):774 - 780, Refereed

BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests.
Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Iwasaki A; Okamoto T; Oda Y; Honda H; Nabeshima K
Pathol Int, 01 Dec. 2016, 66(10):563 - 580, Refereed

Low homozygous/high heterozygous deletion status by p16 FISH correlates with a better prognostic group than high homozygous deletion status in malignant pleural mesothelioma
Makoto Hamasaki; Shinji Matsumoto; Sousei Abe; Daisuke Hamatake; Toshiaki Kamei; Kenzo Hiroshima; Kunimitsu Kawahara; Ayuko Sato; Tohru Tsujimura; Yukio Nakatani; Yasuhiro Yoshida; Akinori Iwasaki; Kazuki Nabeshima
LUNG CANCER, Sep. 2016, 99:155 - 161, Refereed

Tumor budding and laminin5-γ2 in squamous cell carcinoma of the external auditory canal are associated with shorter survival.
Okado Y; Aoki M; Hamasaki M; Koga K; Sueta T; Shiratsuchi H; Oda Y; Nakagawa T; Nabeshima K
Springerplus., 01 Dec. 2015, 24(4):814, Refereed

Deletion status of p16 in effusion smear preparation correlates with that of underlying malignant pleural mesothelioma tissue.
Hida T; Matsumoto S; Hamasaki M; Kawahara K; Tsujimura T; Hiroshima K; Kamei T; Taguchi K; Iwasaki A; Oda Y; Honda H; Nabeshima K
Cancer Sci., 01 Jun. 2015, 106(11):1635 - 1641, Refereed

Clinicopathological analysis of pleomorphic carcinoma of the lung: Diffuse ZEB1 expression predicts poor survival
So Miyahara; Makoto Hamasaki; Daisuke Hamatake; Shin-ichi Yamashita; Takeshi Shiraishi; Akinori Iwasaki; Kazuki Nabeshima
LUNG CANCER, Jan. 2015, 87(1):39 - 44, Refereed

p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Hyperplasia and Epithelial Ovarian Cancer.
Ito T; Hamasaki M; Matsumoto S; Hiroshima K; Tsujimura T; Kawai T; Shimao Y; Marutsuka K; Moriguchi S; Maruyama R; Miyamoto S; Nabeshima K
Am J Clin Pathol., 01 Jan. 2015, 143(6):830 - 838, Refereed

Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component.
Matsumoto S; Nabeshima K; Hamasaki M; Shibuta T; Umemura T
Med Oncol., 01 Dec. 2014, 31(12):303, Refereed

Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: Possible involvement of c-Met
SATO Keisuke; NIMURA Satoshi; AOKI Mikiko; HAMASAKI Makoto; IWASAKI Hiroshi; KOGA Kaori; YAMASHITA Yuichi; NABESHIMA Kazuki
Canser Sci., Nov. 2014, 105(11):1487 - 1495

Association of c-Met phosphorylation with micropapillary pattern and small cluster invasion in pT1-size lung adenocarcinoma
Kaori Koga; Makoto Hamasaki; Fumiaki Kato; Mikiko Aoki; Hiroyuki Hayashi; Akinori Iwasaki; Hiroaki Kataoka; Kazuki Nabeshima
LUNG CANCER, Dec. 2013, 82(3):413 - 419, Refereed

Identification of APN/CD13 as the target antigen of FU3, a human monoclonal antibody that recognizes malignant fibrous histiocytoma.
Aoki M; Nabeshima K; Hayashi H; Hamasaki M; Iwasaki H
Int J Oncol., 01 Jul. 2013, 43(1):57 - 62, Refereed

Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia
Taishi Harada; Kentaro Watanabe; Kazuki Nabeshima; Makoto Hamasaki; Hiroshi Iwasaki
RESPIROLOGY, Feb. 2013, 18(2):278 - 283, Refereed

Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma
Ai Mogi; Kaori Koga; Mikiko Aoki; Makoto Hamasaki; Noriko Uesugi; Akinori Iwasaki; Takayuki Shirakusa; Kazuo Tamura; Kazuki Nabeshima
VIRCHOWS ARCHIV, Jan. 2013, 462(1):83 - 93, Refereed

Invasion of the inner and outer layers of the visceral pleura in pT1 size lung adenocarcinoma measuring ≤ 3 cm: correlation with malignant aggressiveness and prognosis.
Makoto Hamasaki; Fumiaki Kato; Kaori Koga; Hiroyuki Hayashi; Mikiko Aoki; Yoshihiro Miyake; Akinori Iwasaki; Kazuki Nabeshima
VIRCHOWS ARCHIV, Nov. 2012, 461(5):513 - 519, Refereed

Expression patterns of emmprin and monocarboxylate transporter-1 in ovarian epithelial tumors
Miyoko Fukuoka; Makoto Hamasaki; Kaori Koga; Hiroyuki Hayashi; Mikiko Aoki; Tatsuhiko Kawarabayashi; Shingo Miyamoto; Kazuki Nabeshima
VIRCHOWS ARCHIV, Oct. 2012, 461(4):457 - 466, Refereed

Clinicopathological characteristics of subcentimeter adenocarcinomas of the lung
Fumiaki Kato; Makoto Hamasaki; Yoshihiro Miyake; Akinori Iwasaki; Hiroshi Iwasaki; Kazuki Nabeshima
LUNG CANCER, Sep. 2012, 77(3):495 - 500, Refereed

Synthetic emmprin peptides inhibit tumor cell-fibroblast interaction-stimulated upregulation of MMP-2 and tumor cell invasion.
Koga K; Aoki M; Sameshima T; Hamasaki M; Egawa N; Seiki M; Toole BP; Suzumiya J; Nabeshima K
Int J Oncol., 01 Nov. 2011, 39(3):657 - 664, Refereed

Expression of laminin 5-γ2 chain in cutaneous squamous cell carcinoma and its role in tumour invasion.
amasaki H; Koga K; Aoki M; Hamasaki M; Koshikawa N; Seiki M; Iwasaki H; Nakayama J; Nabeshima K
Br J Cancer., 01 Sep. 2011, 105(6):824 - 832, Refereed

Immunohistochemical analysis of laminin 5-γ2 chain expression for differentiation of basal cell carcinoma from trichoblastoma.
Haruka Hamasaki; Kaori Koga; Makoto Hamasaki; Hiromaro Kiryu; Juichiro Nakayama; Hiroshi Iwasaki; Kazuki Nabeshima
HISTOPATHOLOGY, Jul. 2011, 59(1):159 - 161

Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.
Hayashi H; Nabeshima K; Aoki M; Hamasaki M; Enatsu S; Yamauchi Y; Yamashita Y; Iwasaki H
Int J Cancer., 01 Jun. 2010, 126(11):2563 - 2574, Refereed

Epithelial-mesenchymal transition in human lungs with usual interstitial pneumonia: quantitative immunohistochemistry.
Harada T; Nabeshima K; Hamasaki M; Uesugi N; Watanabe K; Iwasaki H
Pathol Int., 01 Jan. 2010, 60(1):14 - 21, Refereed

Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.
Hayashi H; Nabeshima K; Aoki M; Hamasaki M; Enatsu S; Yamauchi Y; Yamashita Y; Iwasaki H
Int J Cancer., Jan. 2010, 126(11):2563 - 74, Refereed

Epithelial-mesenchymal transition in human lungs with usual interstitial pneumonia: quantitative immunohistochemistry.
Harada T; Nabeshima K; Hamasaki M; Uesugi N; Watanabe K; Iwasaki H
Pathol Int., Jan. 2010, 60(1):14 - 21, Refereed

Micrometastasis of Breast Cancer in the Sentinel Lymph Nodes
YOSHINAGA Yasuteru; HAGIO Yasuko; FUKUYO Maya; IWASAKI Akinori; IDA Mikiko; FUJIMITSU Ritsuko; HAMASAKI Makoto; NABESHIMA Kazuki
Med. Bull. Fukuoka Univ., 2010, 37(2):67 - 72, Refereed

Epithelial-mesenchymal transition in human lungs with usual interstitial pneumonia: Quantitative immunohistochemical analysis
Pathology international, 2010, 60:14 - 21

Pleural malignant mesothelioma with invasive micropapillary component and its association with pulmonary metastasis.
Pleural malignant; mesothelioma with; invasive micropapillary component; its association with; pulmonary metastasis
Pathol Int., Dec. 2009, 59(12):874 - 9, Refereed

Pathology of soft-tissue tumors: daily diagnosis, molecular cytogenetics and experimental approach.
Iwasaki H; Nabeshima K; Nishio J; Jimi S; Aoki M; Koga K; Hamasaki M; Hayashi H; Mogi A
Pathol Int., Aug. 2009, 59(8):501 - 21, Refereed

Presence of microsatellite lesions with colorectal liver metastases correlate with intrahepatic recurrence after surgical resection.
Hayashi H; Nabeshima K; Hamasaki M; Yamashita Y; Shirakusa T; Iwasaki H
Oncol Rep., May 2009, 21(3):601 - 7, Refereed

Up-regulated expression of ADAM17 in gastrointestinal stromal tumors: coexpression with EGFR and EGFR ligands.
Nakagawa M; Nabeshima K; Asano S; Hamasaki M; Uesugi N; Tani H; Yamashita Y; Iwasaki H
Cancer Sci., Apr. 2009, 100(4):654 - 62, Refereed

Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
Oncol Rep., Jun. 2008, 19(6):1413 - 20, Refereed

Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB.
Aoki M; Nabeshima K; Koga K; Hamasaki M; Suzumiya J; Tamura K; Iwasaki H
Lab Invest., Aug. 2007, 87(8):767 - 79, Refereed

Imatinib mesilate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB
AOKI Mikiko; NABESHIMA Kazuki; KOGA Kaori; HAMASAKI Makoto; SUZUMIYA Junji; TAMURA Kazuo; IWASAKI Hiroshi
Laboratory Investigation, Aug. 2007, 87(8):767 - 779, Refereed

Dissecting aneurysms involving both anterior cerebral artery and aorta.
Sakata N; Hamasaki M; Iwasaki H; Shigekawa S; Arai S
Pathol Int, Apr. 2007, 57(4):224 - 8

Emmprin in epithelioid sarcoma: Expression in tumor cell membrane and stimulation of MMP-2 production in tumor-associated fibroblasts.
Koga K; Nabeshima K; Aoki M; Kawakami T; Hamasaki M; Toole BP; Nakayama J; Iwasaki H
Int J Cancer, 2007, 120(4):761 - 8

Micropapillary pattern and grade of stromal invasion in pT1 adenocarcinoma of the lung: usefulness as prognostic factors.
Kawakami T; Nabeshima K; Makimoto Y; Hamasaki M; Iwasaki A; Shirakusa T; Iwasaki H
Mod Pathol, 2007, 20(5):514 - 21

Establishment of three malignant peripheral nerve sheath tumor cell lines, FU-SFT8611, 8710 and 9817: Conventional and molecular cytogenetic characterization
AOKI Mikiko; NABESHIMA Kazuki; NISHIO Jun; ISHIGURO Masako; FUJITA Chikako; KOGA KAori; HAMASAKI Makoto; IWASAKI Hiroshi
Int J Oncol, Dec. 2006, 29(6):1421 - 8, Refereed

The value of tumor volume in surgically resected non-small cell lung cancer.
Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Hamada T; Hamasaki M
Thorac Cardiovasc Surg., May 2006, 54(2):112 - 6

Expression of hypoxia-inducible factor-1 alpha and its prognostic significance in small-sized adenocarcinomas of the lung
ENATSU Sotaro; IWASAKI Akinori; SHIRAKUSA Takayuki; HAMASAKI Makoto; NABESHIMA Kazuki; IWASAKI Hiroshi; KUROKI Motomu; KUROKI Masahide
Eur J Cardiothorac Surg, 2006, 29:891 - 895, Refereed

Establishment of three malignant peripheral nerve sheath tumor cell lines, FU-SFT8611, 8710 and 9817: conventional and molecular cytogenetic characterization.
Aoki M; Nabeshima K; Nishio J; Ishiguro M; Fujita C; Koga K; Hamasaki M; Kaneko Y; Iwasaki H
Int J Oncol, 2006, 29(6):1421 - 8

Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway.
Ishitsuka K; Hideshima T; Hamasaki M; Raje N; Kumar S; Podar K; Le Gouill S; Shiraishi N; Yasui H; Roccaro AM; Tai YZ; Chauhan D; Fram R; Tamura K; Jain J; Anderson KC
Oncogene., Nov. 2005, 24(38):5888 - 96

Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis.
Ishitsuka K; Hideshima T; Hamasaki M; Raje N; Kumar S; Hideshima H; Shiraishi N; Yasui H; Roccaro AM; Richardson P; Podar K; Le Gouill S; Chauhan D; Tamura K; Arbiser J; Anderson KC
Blood., Nov. 2005, 106(5):1794 - 800

FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
Cancer Res., Aug. 2005, 65(16):7478 - 84

Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs.
Kumar S; Raje N; Hideshima T; Ishitsuka K; Roccaro A; Shiraishi N; Hamasaki M; Yasui H; Munshi NC; Richardson P; Figg WD; Anderson KC
Leukemia., Jul. 2005, 19(7):1253 - 61

SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma.
Yasui H; Hideshima T; Hamasaki M; Roccaro AM; Shiraishi N; Kumar S; Tassone P; Ishitsuka K; Raje N; Tai YT; Podar K; Chauhan D; Leoni LM; Kanekal S; Elliott G; Munshi NC; Anderson KC
Blood., Jul. 2005, 106(2):706 - 12

Differential expression of cytokines, chemokines and their receptors in follicular lymphoma and reactive follicular hyperplasia: assessment by complementary DNA microarray.
Fujii A; Oshima K; Hamasaki M; Utsunomiya H; Okazaki M; Kagami Y; Seto M; Kikuchi M
Oncol Rep., May 2005, 13(5):189 - 24

Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo.
Hamasaki M; Hideshima T; Tassone P; Neri P; Ishitsuka K; Yasui H; Shiraishi N; Raje N; Kumar S; Picker DH; Jacob GS; Richardson PG; Munshi NC; Anderson KC
Blood, Jan. 2005, 105(11):4470 - 6, Refereed

Gene Expression in Adult T Cell Leukemia/Lymphoma: Up-Regulation of Matrix Metalloproteinase 2 in Skin Lesions.
Karube K; Ohshima K; Hamasaki M; Tsuchiya T; Yamaguchi T; Suefuji H; Suzumiya J; Nabeshima K; Utsunomiya A; Harada M; Kikuchi M
J Clin. Exp.Hematopathol., Dec. 2004, 44(2)

Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment.
Hayashi T; Hideshima T; Nguyen AN; Munoz O; Podar K; Hamasaki M; Ishitsuka K; Yasui H; Richardson P; Chakravarty S; Murphy A; Chauhan D; Higgins LS; Anderson KC
Clin Cancer Res., Nov. 2004, 10(22):7540 - 6

p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells.
Hideshima T; Podar K; Chauhan D; Ishitsuka K; Mitsiades C; Tai YT; Hamasaki M; Raje N; Hideshima H; Schreiner G; Nguyen AN; Navas T; Munshi NC; Richardson PG; Higgins LS; Anderson KC
Oncogene, Nov. 2004, 23(54):8766 - 76

Apoptosis- and cell cycle-associated gene expression profiling of histiocytic necrotising lymphadenitis.
Ohshima K; Karube K; Hamasaki M; Makimoto Y; Fujii A; Kawano R; Tutiya T; Yamaguchi T; Suzumiya J; Kikuchi M
Eur J Haematol., May 2004, 72(5):322 - 9

Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: clinical implications.
Tai YT; Catley LP; Mitsiades CS; Burger R; Podar K; Shringpaure R; Hideshima T; Chauhan D; Hamasaki M; Ishitsuka K; Richardson P; Treon SP; Munshi NC; Anderson KC
Cancer Res., Apr. 2004, 64(8):2846 - 52, Refereed

Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells.
Fujiwara M; Kamma H; Wu W; Hamasaki M; Kaneko S; Horiguchi H; Matsui-Horiguchi M; Satoh H
Int J Oncol., Apr. 2004

Differential expression of chemokines, chemokine receptors, cytokines and cytokine receptors in diffuse large B cell malignant lymphoma.
Fujii A; Ohshima K; Hamasaki M; Makimoto Y; Haraoka S; Utsunomiya H; Okazaki M; Kikuchi M
Int J Oncol., Mar. 2004, 24(3):529 - 38

Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL.
Tsuchiya T; Ohshima K; Karube K; Yamaguchi T; Suefuji H; Hamasaki M; Kawasaki C; Suzumiya J; Tomonaga M; Kikuchi M
Blood., Jan. 2004, 103(1):236 - 41

Imbalances of chemokines, chemokine receptors and cytokines in Hodgkin lymphoma: classical Hodgkin lymphoma vs. Hodgkin-like ATLL.
Ohshima K; Karube K; Hamasaki M; Suefuji H; Tutiya T; Yamaguchi T; Suzumiya J; Kikuchi M
Int J Cancer., Nov. 2003, 106(5):706 - 12

Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells.
Akiyama M; Hideshima T; Shammas MA; Hayashi T; Hamasaki M; Tai YT; Richardson P; Gryaznov S; Munshi NC; Anderson KC
Cancer Res., Oct. 2003, 63(19):6187 - 94

Differential chemokine, chemokine receptor, cytokine and cytokine receptor expression in pulmonary adenocarcinoma: diffuse down-regulation is associated with immune evasion and brain metastasis.
Ohshima K; Hamasaki M; Makimoto Y; Yoneda S; Fujii A; Takamatsu Y; Nakashima M; Watanabe T; Kawahara K; Kikuchi M; Shirakusa T
Int J Oncol., Oct. 2003, 23(4):965 - 73

Differential chemokine, chemokine receptor and cytokine expression in Epstein-Barr virus-associated lymphoproliferative diseases.
Ohshima K; Karube K; Hamasaki M; Tutiya T; Yamaguchi T; Suefuji H; Suzuki K; Suzumiya J; Ohga S; Kikuchi M
Leuk Lymphoma., Aug. 2003, 44(8):1367 - 78

Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
Leuk Lymphoma., Aug. 2003, 44(8):1339 - 46

Reduced expression of heterogeneous nuclear ribonucleoprotein B1 in adult T-cell lymphoma/leukemia.
Tani H; Ohshima K; Haraoka S; Hamasaki M; Kamma H; Ikeda S; Kikuchi M
Int J Oncol., Mar. 2003, 22(3):529 - 34

Expression of chemokine receptor CXCR3 and its ligand, mig, in gastric and thyroid marginal zone lymphomas. Possible migration and autocrine mechanism.
Ohshima K; Suefuji H; Karube K; Hamasaki M; Hatano B; Tutiya T; Yamaguchi T; Suzuki K; Suzumiya J; Kikuchi M
Leuk Lymphoma., Feb. 2003, 44(2):329 - 36

Overexpression of heterogeneous nuclear ribonucleoprotein B1 in lymphoproliferative disorders: high expression in cells of follicular center origin.
Tani H; Ohshima K; Haraoka S; Hamasaki M; Kamma H; Ikeda S; Kikuchi M
Int J Oncol., Nov. 2002, 21(5):957 - 63

Expression of hnRNP B1 in four major histological types of lung cancers.
Hamasaki M; Kamma H; Wu W; Kaneko S; Fujiwara M; Satoh H; Haraoka S; Kikuchi M; Shirakusa T
Anticancer Research, Mar. 2001, 21(2A):979 - 84

がんとエビデンス、がんと生物学
濵﨑 慎; 鍋島一樹, Others, 第2章 総論
01 Dec. 2012

FISHにて9p21ホモ接合性欠失を示す胸膜悪性中皮腫細胞の形態学的特徴
鍋島一樹; 松本慎二; 濵﨑 慎; 大神明子; 亀井敏昭; 岩崎昭憲, Contributor
01 Dec. 2012

移植摘出肺（インジウム肺）の病理組織像
第11回インジウム情報交換会, 22 May 2018

悪性胸膜中皮腫と良性中皮過形成の鑑別におけるMTAPIHC及びBAP1IHCの有用性.
木下 義晃; 樋田 知之; 濱崎慎; 松本慎二; 辻村亨; 佐藤鮎子; 河原邦光; 廣島健三; 小田義直; 鍋島一樹
第58回日本肺癌学会学術集会, 14 Oct. 2017

外耳道癌における腫瘍細胞のemmprinと間質のCD73の高発現は独立した予後不良因子である.
宮崎健; 青木光希子; 古賀佳織; 濱崎慎; 中川尚志; 坂田俊文; 鍋島一樹
第76回日本癌学会学術総会, 28 Sep. 2017

Intraoperative Squash/Crush Preparation Cytology of Brain Lesions: A 20-Year Retrospective Analysis.
Karen HF Chang; 濱崎 慎; 鍋島一樹; Pamela S Tauchi-Nishi
第106回日本病理学会総会, 27 Apr. 2017

An autopsy case of sarcomatoid mesothelioma.
Ogawa Y; Aoki M; Mihashi Y; Hamasaki M; Sasaki T; Watanabe K; Takeshita M; Nabeshima K
第106回日本病理学会総会, 27 Apr. 2017

Pleuroparenchymal fibroelastosis及びIdiopathic pulmonary fibrosisにおける弾性線維の肺内分布の検討.
木下 義晃; 渡辺憲太朗; 吉村雅代; 濱崎慎; 石井寛; 串間尚子; 藤田昌樹; 鍋島一樹
第106回日本病理学会総会, 27 Apr. 2017

前縦隔に発育した悪性孤立性線維性腫瘍の1切除例
濵﨑 慎; 吉田 康治; 青木 光希子; 宮原 聡; 樋田 智之; 岩崎 昭憲; 鍋島 一樹
第56回日本肺癌学会総会, 26 Nov. 2015

悪性胸膜中皮腫のp16 FISHにおけるホモ接合性欠失とヘテロ接合性欠失
阿部創世; 濱崎 慎; 松本慎二; 亀井敏昭; 廣島健三; 河原邦光; 辻村 亨; 岩崎昭憲; 鍋島一樹
第104回日本病理学会総会, 30 Apr. 2015

高齢者における直腸穿通、腹腔内破裂および腹膜炎を伴った右卵巣成熟嚢胞奇形腫悪性転化の一剖検例
彌重このみ; 濵﨑 慎; 清島千尋; 鍋島一樹
第104回日本病理学会総会, 30 Apr. 2015

p16 FISH deletion status in effusion smear preparations correlates with that in underlying malignant pleural mesothelioma
Hida T; Matsumoto S; Hamasaki M; Abe S; Tsujimura T; Hiroshima K; K. Nabeshima
The 104th United States and Canadian Academy of Pathology, 21 Mar. 2015

悪性胸膜中皮腫の診断におけるp16 FISH
阿部創世; 濱崎 慎; 松本慎二; 亀井敏昭; 廣島健三; 河原邦光; 辻村 亨; 岩崎昭憲; 鍋島一樹
第55 回日本肺癌学会学術集会, 14 Nov. 2014

乳腺病変に対する造影超音波time intensity curve解析の有用性
FUJIMITSU Ritsuko; SHIMAKURA Mikiko; YOSHINAGA Yasuteru; NABESHIMA Kazuki; HAMASAKI Makoto; ENOMOTO Yasuko; YOSHIMITSU Kengo
第22回日本乳癌学会学術総会, 10 Jul. 2014

肺内多発粒状影を呈するmiliary mesotheliomaの1例
大坪千恵子; 濵﨑 慎; 松本慎二; 鍋島一樹; 高倉孝二
第103回日本病理学会総会, 24 Apr. 2014

術前化学療法前後で画像上性状変化が追えた浸潤性乳管癌の1例
FUJIMITSU Ritsuko; YOSHINAGA Yasuteru; NABESHIMA Kazuki; HAMASAKI Makoto; YOSHIMITSU Kengo
The 11 Kyushu regional meetig of Japanese breast cancer society, 01 Mar. 2014

胸膜悪性中皮腫組織標本におけるp16 (9p21)遺伝子欠失の同定(FISH法)
濵﨑 慎; 鍋島一樹; 松本慎二; 亀井敏昭; 廣島健三; 辻村 亨; 岩崎 昭憲
第53回日本肺癌学会総会, 08 Nov. 2012

Morphological Characteristics of Pleural Mesothelioma Cells Harboring 9p21 Homozygous Deletion Detected by Fluorescence in Situ Hybridization (FISH) in Effusion Cytology
M. Hamasaki; S. Matsumoto; K. Nabeshima; T. Kamei; K. Hiroshima; Y. Matsuno; K. Kawahara; T. Tsujimura
The 101th United States and Canadian Academy of Pathology, 17 Mar. 2012

Invasion of the Inner and Outer Layers of the Visceral Pleura in pT1 Lung Adenocarcinoma: Correlation with Malignant Aggressiveness and Prognosis
M. Hamasaki; F. Kato; Y. Miyake; A. Iwasaki; K. Nabeshima
IASLC 14th world conference of lung cancer, 03 Jul. 2011

マンモグラフィにおける石灰化病変の形態学的検討
FUJIMITSU Ritsuko; IDA Mikiko; YOSHINAGA Yasuteru; NABESHIMA Kazuki; HAMASAKI Makoto; YOSHIMITSU Kengo; OKAZAKI Masatoshi
tThe 18th annual meeting of the Japanese breast cancer society, 24 Jun. 2010

Immunohistochemical detection of monocarboxylate transporters (MCT) and GLUT-1 in pleural malignant mesothelioma and reactive mesothelial hyperplasia: A useful tool for the differential diagnosis
M. Hamasaki; A. Mogi; K. Nabeshima; N. Uesugi; K. Tamura; A. Iwasaki; T. Shirakusa; H. Iwasaki
USCAP, Mar. 2010

小型肺腺癌における予後因子としての微小乳頭状構造(micropapillary pattern): 臨床病理学的解析と浸潤形態
濵﨑 慎; 鍋島一樹; 川上豪仁; 岩崎明憲
第2回福岡医学会総会, 31 Jan. 2010

EMBRYONAL RHABDOMYOSARCOMA WITH PSEUDOALVEOLAR PATTERN
Makoto Hamasaki, M.D; Kazuki Nabeshima, M.D; Hiroyuki Hayashi, M.D; Mikiko Aoki, M.D; Kaori Koga, M.D; Hiroshi Iwasaki M.D
第55回日本病理学会秋期特別総会, Nov. 2009

McCune-Albright症候群にOsteosarcomaを合併した1症例
濵﨑慎; 青木光希子; 鍋島一樹; 有村和子; 小坂正明; 佐々木秀法; 岩﨑宏
第41回日本整形学会骨・軟部腫瘍学術集会, Jul. 2008

日本病理学会

日本臨床細胞学会

日本外科学会

日本癌学会

日本乳癌学会

日本結合組織学会

日本肺癌学会

国際病理アカデミー日本支部